Literature DB >> 10599795

Reduction of intracerebral hemorrhaging in a rabbit embolic stroke model.

B Hu1, C Liu, J A Zivin.   

Abstract

OBJECTIVE: To study the effects of a spin trap agent and a CD18 antibody administered after stroke induction on intracerebral hemorrhaging. The drugs can prevent leukocyte adhesion.
METHODS: A rabbit embolic stroke model that produces intracerebral hemorrhage was used.
RESULTS: A time course study showed that hemorrhaging was grossly apparent in approximately 50% of the subjects at 5 hours and in 75% at 24 hours after embolization. MDL 101,002, a spin trap agent, administered IV 5 minutes after embolization, significantly decreased the volume of hemorrhage. It also improved the behavior score relative to vehicle-treated rabbits. The CD18 antibody tended to decrease hemorrhage volume.
CONCLUSION: The beneficial effect of MDL 101,002 may be caused by inhibition of free radical injury to brain tissue, thereby protecting brain microvessel integrity. Acute therapy for intracerebral hemorrhage may be feasible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599795     DOI: 10.1212/wnl.53.9.2140

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  A new embolus injection method to evaluate intracerebral hemorrhage in New Zealand white rabbits.

Authors:  Paul A Lapchak
Journal:  Brain Res       Date:  2010-06-21       Impact factor: 3.252

Review 2.  Inflammatory Profiles of the Interleukin Family and Network in Cerebral Hemorrhage.

Authors:  Lei Ye; Lu Gao; Hongwei Cheng
Journal:  Cell Mol Neurobiol       Date:  2018-07-19       Impact factor: 5.046

Review 3.  Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.

Authors:  Paul A Lapchak
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

4.  Reduced brain injury in CD18-deficient mice after experimental intracerebral hemorrhage.

Authors:  Elena Titova; Robert P Ostrowski; Christopher G Kevil; Wenni Tong; Hugo Rojas; Lawrence C Sowers; John H Zhang; Jiping Tang
Journal:  J Neurosci Res       Date:  2008-11-01       Impact factor: 4.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.